WELL Health Reports Record Results for Q2-2024 Driven by an Acceleration in Organic Growth and Raises Annual Guidance
WELL achieved record quarterly revenues of $243.1 million in Q2-2024, an increase of 42% as compared to Q2-2023 driven by...
WELL achieved record quarterly revenues of $243.1 million in Q2-2024, an increase of 42% as compared to Q2-2023 driven by...
New framework enables health systems self-assess their current state of virtual care in patient care delivery; offers tailored recommendations for...
Latest Round of Financing, Led by Sapphire Ventures, Establishes EliseAI’s Unicorn StatusNEW YORK--(BUSINESS WIRE)--EliseAI, the largest and most advanced conversational...
Latest Round of Financing, Led by Sapphire Ventures, Establishes EliseAI’s Unicorn StatusNEW YORK--(BUSINESS WIRE)--EliseAI, the largest and most advanced conversational...
Revealia™, the world’s most convenient cancer screening test, to launch in 2024 SPARKS, NV / ACCESSWIRE / August 14, 2024...
Growing USME team supporting rising number of hospitals nationwide as the company recommits to Houston with new headquartersHOUSTON, TX /...
Company provides nearly 80% statewide comprehensive insurance coverage in Utah under contract with providers such as Medicare, Select Health, Medicaid,...
TAMPA, FL / ACCESSWIRE / August 14, 2024 / Full Alliance Group, Inc. (OTC PINK:FAGI) is pleased to announce that...
SIRE Veterinario, SA Selected as Distribution Partner to Launch Zomedica® Products into Costa Rica ANN ARBOR, MI / ACCESSWIRE /...
GARDNER, Mass., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI) (the “Company”), a leading designer and...
Sheridan Community Hospital is the First Healthcare Institution in Michigan With Nociscan Agreement Expands Nociscan Access to John Keller, MD,...
Declared development candidate MGX-001 for the treatment of hemophilia A; plans to present 12-month NHP durability study data in September...
PEMGARDA™ launched commercially in Q2 2024 with $2.3 million of net product revenueNotable acceleration of commercial results in early Q3...
SEATTLE, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome...
Expects to report topline results in 2025 from Phase 2a influenza A human challenge study with oral CC-42344, including initial...
Company Anticipates Significant Sequential Growth in Quarterly Revenues Beginning in Q3 2024 and Beyond Reports Pharmaloz Growth Acceleration Has Begun...
California Bars and Clubs Are Now Mandated to Offer Date Rape Drug Test KitsSafety Strips is First to Achieve Mass-Scale...
Regulatory milestone validates the SOPHiA DDM™ Platform as diagnostic tool in select markets BOSTON and ROLLE, Switzerland, Aug. 14, 2024 /PRNewswire/...
COPENHAGEN, Denmark, Aug. 14, 2024 /PRNewswire/ -- The Novo Nordisk Foundation and the Export and Investment Fund of Denmark (EIFO) are...
Softness in market for Shared R&D Services, with H1 2024 revenues down 7% year-on-year. Continued growth of sales order book...